Programmed cell death 4 mechanism of action: The model to be updated?

References

• Lankat-Buttgereit B, Göke R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell. 2009;101:309-17. doi:10.1042/BC20080191. PMID:19356152
   PubMed Web of Science ®Google Scholar
• Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol. 2003;23:26-37. doi:10.1128/MCB.23.1.26-37.2003. PMID:12482958
   PubMed Web of Science ®Google Scholar
• Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, Colburn NH. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 2004;24:3894-906. doi:10.1128/MCB.24.9.3894-3906.2004. PMID:15082783.
   PubMed Web of Science ®Google Scholar
• LaRonde-LeBlanc N, Santhanam AN, Baker AR, Wlodawer A, Colburn NH. Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol. 2007;27:147-56. doi:10.1128/MCB.00867-06. PMID:17060447
   PubMed Web of Science ®Google Scholar
• Loh PG, Yang HS, Walsh MA, Wang Q, Wang X, Cheng Z, Liu D, Song H. Structural basis for translational inhibition by the tumour suppressor Pdcd4. EMBO J. 2009;28:274-85. doi:10.1038/emboj.2008.278. PMID:19153607
   PubMed Web of Science ®Google Scholar
• Suzuki C, Garces RG, Edmonds KA, Hiller S, Hyberts SG, Marintchev A, Wagner G. PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc Natl Acad Sci USA. 2008;105:3274-9. doi:10.1073/pnas.0712235105. PMID:18296639
   PubMed Web of Science ®Google Scholar
• Dorrello NV, Peschiaroli A, Guardavaccaro D, Colburn NH, Sherman NE, Pagano M. S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science. 2006;314:467-71. doi:10.1126/science.1130276. PMID:17053147
   PubMed Web of Science ®Google Scholar
• Schmid T, Jansen AP, Baker AR, Hegamyer G, Hagan JP, Colburn NH. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res. 2008;68:1254-60. doi:10.1158/0008-5472.CAN-07-1719. PMID:18296647
   PubMed Web of Science ®Google Scholar
• Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 2008;27:4373-9. doi:10.1038/onc.2008.72. PMID:18372920
   PubMed Web of Science ®Google Scholar
• Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350-9. doi:10.1038/cr.2008.24. PMID:18270520
   PubMed Web of Science ®Google Scholar
• Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008;27:2128-36. doi:10.1038/sj.onc.1210856. PMID:17968323
   PubMed Web of Science ®Google Scholar
• Vikhreva PN, Shepelev MV, Korobko IV. mTOR-dependent transcriptional repression of Pdcd4 tumor suppressor in lung cancer cells. Biochim Biophys Acta. 2014;1839:43-9. doi:10.1016/j.bbagrm.2013.12.001. PMID:24334141
   PubMed Web of Science ®Google Scholar
• Modelska A, Turro E, Russell R, Beaton J, Sbarrato T, Spriggs K, Miller J, Gräf S, Provenzano E, Blows F, et al. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape. Cell Death Dis. 2015;6:e1603. doi:10.1038/cddis.2014.542. PMID:25611378
   PubMed Web of Science ®Google Scholar
• Chu J, Pelletier J. Targeting the eIF4A RNA helicase as an anti-neoplastic approach. Biochim Biophys Acta. 2015;1849:781-91. doi:10.1016/j.bbagrm.2014.09.006. PMID:25234619
   PubMed Web of Science ®Google Scholar
• Rubio CA, Weisburd B, Holderfield M, Arias C, Fang E, DeRisi JL, Fanidi A. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation. Genome Biol. 2014;15:476. doi:10.1186/s13059-014-0476-1. PMID:25273840
   PubMed Web of Science ®Google Scholar
• Biyanee A, Ohnheiser J, Singh P, Klempnauer KH. A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation. Oncogene. 2015;34:1384-92. doi:10.1038/onc.2014.83. PMID:24681950
   PubMed Web of Science ®Google Scholar
• Biyanee A, Singh P, Klempnauer KH. Translation, Pdcd4 and eIF4A. Oncoscience. 2015;2:731-2. PMID:26501070
   PubMedGoogle Scholar
• Singh P, Wedeken L, Waters LC, Carr MD, Klempnauer KH. Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation. Oncogene. 2011;30:4864-73. doi:10.1038/onc.2011.202. PMID:21643008
   PubMed Web of Science ®Google Scholar
• Lankat-Buttgereit B, Göke R. Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy? Biol Cell. 2003;95:515-9. doi:10.1016/j.biolcel.2003.09.003. PMID:14630388
   PubMed Web of Science ®Google Scholar
• Raza F, Waldron JA, Quesne JL. Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence. Biochem Soc Trans. 2015;43:1227-33. doi:10.1042/BST20150163. PMID:26614665
   PubMed Web of Science ®Google Scholar
• Kalinichenko SV, Kopantzev EP, Korobko EV, Palgova IV, Zavalishina LE, Bateva MV, Petrov AN, Frank GA, Sverdlov ED, Korobko IV. Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors. Lung Cancer. 2008;62:173-80. doi:10.1016/j.lungcan.2008.03.022. PMID:18457901
   PubMed Web of Science ®Google Scholar
• Böhm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R, Klempnauer KH. The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene. 2003;22:4905-10. doi:10.1038/sj.onc.1206710. PMID:12894233
   PubMed Web of Science ®Google Scholar
• Lim SC, Hong R. Programmed cell death 4 (Pdcd4) expression in colorectal adenocarcinoma: Association with clinical stage. Oncol Lett. 2011;2:1053-7. PMID:23049623
   PubMed Web of Science ®Google Scholar
• Kakimoto T, Shiraishi R, Iwakiri R, Fujimoto K, Takahashi H, Hamajima H, Mizuta T, Ideguchi H, Toda S, Kitajima Y, et al. Expression patterns of the tumor suppressor PDCD4 and correlation with β-catenin expression in gastric cancers. Oncol Rep. 2011;26:1385-92. PMID:21894439
   PubMed Web of Science ®Google Scholar
• Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Pucciarelli S, Rugge M. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch. 2011;458:413-9. doi:10.1007/s00428-011-1046-5. PMID:21279518
   PubMed Web of Science ®Google Scholar
• Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH, Post S, Jansen A, Colburn NH, Allgayer H. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer. 2007;110:1697-707. doi:10.1002/cncr.22983. PMID:17849461
   PubMed Web of Science ®Google Scholar
• Palamarchuk A, Efanov A, Maximov V, Aqeilan RI, Croce CM, Pekarsky Y. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res. 2005;65:11282-6. doi:10.1158/0008-5472.CAN-05-3469. PMID:16357133
   PubMed Web of Science ®Google Scholar
• Dang FW, Chen L, Madura K. Catalytically Active Proteasomes Function Predominantly in the Cytosol. J Biol Chem. 2016;291:18765-77. doi:10.1074/jbc.M115.712406. PMID:27417138
   PubMed Web of Science ®Google Scholar